IT and IV Lentiviral Gene Therapy for X-ALD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IT and IV Lentiviral Gene Therapy for X-ALD — Stella

Home/X-linked Adrenoleukodystrophy/

View on ClinicalTrials.gov

Recruiting

Back to X-linked Adrenoleukodystrophy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong

Key details

Sponsor

Shenzhen Geno-Immune Medical Institute

Enrollment target

~30 participants

Started

August 2025

Primary completion

December 2027

Age range

1 Year – 60 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.